Clinical Trial Update: Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial investigating methylphenidate and exercise to reduce cancer-related fatigue in patients with prostate cancer; the study is currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Carcinoma | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING